Cofoe Medical Technology Co.,Ltd.
Total Valuation
Cofoe Medical Technology Co.,Ltd. carries a market capitalization of 814.86M, placing it among publicly traded companies globally. Its enterprise value stands at -1.61B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 814.86M |
| Enterprise Value | -1.61B |
Share Statistics
Cofoe Medical Technology Co.,Ltd. currently has 208.90M shares outstanding.
| Shares Outstanding | 208.90M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
Cofoe Medical Technology Co.,Ltd. maintains a current ratio of 2.07, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 21.42, indicating elevated leverage, while an interest coverage ratio of 26.49 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.07 |
| Quick Ratio | 1.33 |
| Debt / Equity | 21.42 |
| Debt / EBITDA | 3.11 |
| Interest Coverage | 26.49 |
Financial Efficiency
Cofoe Medical Technology Co.,Ltd. posts a return on equity of 30.92 and a return on invested capital of 4.88.
| Return on Equity (ROE) | 30.92 |
| Return on Assets (ROA) | 4.42 |
| Return on Invested Capital (ROIC) | 4.88 |
| Return on Capital Employed (ROCE) | 16.23 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.95 |
Taxes
Over the trailing twelve months, Cofoe Medical Technology Co.,Ltd. has paid 47.64M in income taxes, reflecting an effective tax rate of 13.97.
| Income Tax | 47.64M |
| Effective Tax Rate | 13.97 |
Stock Price Statistics
Cofoe Medical Technology Co.,Ltd.'s stock has declined approximately -22.41645% over the past 52 weeks. The 50-day moving average sits at 32.52, while the 200-day moving average is 32.52.
| Beta (5Y) | N/A |
| 52-Week Price Change | -22.41645% |
| 50-Day Moving Average | 32.52 |
| 200-Day Moving Average | 32.52 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Cofoe Medical Technology Co.,Ltd. generated 2.76B in revenue and converted that into 294.40M in net income, yielding earnings per share of 1.40. EBITDA reached 328.20M, while operating income came in at 328.20M.
| Revenue | 2.76B |
| Gross Profit | 1.48B |
| Operating Income | 328.20M |
| Pretax Income | 340.93M |
| Net Income | 294.40M |
| EBITDA | 328.20M |
| EBIT | 328.20M |
| Earnings Per Share (EPS) | 1.40 |
Balance Sheet
Cofoe Medical Technology Co.,Ltd. holds 2.67B in cash and equivalents against 1.02B in total debt, resulting in a net debt position of -580.93M. Total book value stands at 839.66M, with working capital of 2.15B providing operational flexibility.
| Cash & Cash Equivalents | 2.67B |
| Total Debt | 1.02B |
| Net Debt | -580.93M |
| Equity (Book Value) | 839.66M |
| Book Value Per Share | 4.08 |
| Working Capital | 2.15B |
Cash Flow
After subtracting -75.44M in capital expenditures, free cash flow totaled -75.44M - equivalent to -0.37 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -75.44M |
| Free Cash Flow | -75.44M |
| FCF Per Share | -0.37 |
Margins
Cofoe Medical Technology Co.,Ltd. operates with a gross margin of 53.63, reflecting its pricing power and cost economics. The operating margin of 11.89 and net profit margin of 10.67 provide insight into operational efficiency.
| Gross Margin | 53.63 |
| Operating Margin | 11.89 |
| Pretax Margin | 12.35 |
| Profit Margin | 10.67 |
| EBITDA Margin | 11.89 |
Dividends & Yields
The company's payout ratio of 85.89 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.22 |
| Dividend Yield | N/A |
| Payout Ratio | 85.89 |
| Shareholder Yield | N/A |
| FCF Yield | N/A |
Scores
Cofoe Medical Technology Co.,Ltd. posts an Altman Z-Score of 1.17, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.17 |